Chennai sero-survey reports 21.5% have Coronavirus Antibodies


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Chennai sero-survey reports 21.5% have Coronavirus Antibodies
In Chennai 12405 were found seropositive

One-fifth of the Chennai's population has been exposed to SARS-CoV-2, the virus that causes Covid 19, according to the preliminary findings of the population-based sero survey in the
Chennai Corporation limits.

Of the 12,405 individuals, across 51 wards, tested for antibody against SARS-CoV-2, 2,673 people had evidence of exposure with a seroprevalence of 21.5%.

Of the 12,405 persons, only 173 had a history of contact with a Covid 19 patient.

The survey was carried out by the National Institute of Epidemiology and the field data collection for this took place between July 18-28. The test positivity rate at the end of July was around 10%.

Seroprevalence is the percentage of individuals of the population to have antibodies against SARS-Cov-2.

"Around 80% of the population is still susceptible to SARS-CoV-2 ingestion in Chennai," the sero survey report, released by the Chennai Corporation on Tuesday, stated.

However, it was found that seroprevalence varied vastly across various zones of Chennai Corporation.

For instance, 44.2% of the samples tested for the survey in Tondiarpet zone were found positive for IgG antibodies against SARS-Cov-2, which means that they have had previous exposure to the virus.

On the other hand, only 7.1% of those tested for the antibodies in the Madhavaram zone were found to have them.

Royapuram, another high-incidence zone, also recorded high seroprevalence of 34.4%. The Perungudi zone was found to have low seroprevalence of 7.3%.

"We need to understand the reasons for varying seroprevalence across zones to improve our control measures," the survey stated.

The ward-wise break up showed that Korukkpet (Ward 47), had 50% seroprevalence. New Washermanpet (Ward 39) had 49% seroprevalence while Mugalivakam (Ward 156) and Lakshmipuram (Ward 32) had the lowest seroprevalence of 2% and 3% respectively.

Meanwhile, out of the overall seroprevalence, women were found to have a higher percentage of seroprevalence (23.7%) when compared to men (19.3%). Across age groups, those between the ages of 10 and 19 had higher seroprevalence of 23.8% whereas those above the age of 60 had the lowest (15.9%).

The results also showed that the Infection to Case ratio (the number of cases of a disease compared to the number of infections with the agent that causes the disease) for the period of 14 July was 22.4%.

This, the survey said, was lower compared to some published studies, indicating high testing.

Apart from this, around 1.35 lakh people in Chennai have been tested positive for Covid 19 out of which 1.19 lakh have recovered as on Tuesday.

Addressing reporters, Chennai Corporation Commissioner G Prakash said that such seroprevalence surveys will continue.

"Wherever seroprevalence is high, reflection of (Covid 19) cases is lower. We can see that they are now stabilising in these areas- this is a natural outcome, the transmission speed will come down where
seroprevalence is high," he said.

"This was done 35 days ago, the seroprevalence will be higher now. It is important to know this because it is only then we will be able to balance interventions. We can increase interventions where seroprevalence is low," he added.

Story Source : https://www.newindianexpress.com 

Tags : #Chennai #SeropostiveChennai #Royapuram #korukkpet #NationalInstituteofEpidimiology #latestChennaiCovidNewsSep2 #GPrakash

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026